Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world study-Reference-Cited by-同舟云学术

Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world study

Published:2016-05-10 Issue:8 Volume:51 Page:979-985
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Doyle Adam¹,Marsh Philip¹,Gill Raghubinder²,Rodov Marcia²,Mohsen Waled²,Varma Poornima³,Hong Thai⁴,Strasser Simone I.²,Bell Sally⁴,Ryan Marno⁴,Nicoll Amanda³⁵,Lubel John⁵,Gow Paul J.⁶,Fink Michael Anthony⁷,Roberts Stuart⁸,Kemp William⁸,Kronborg Ian⁹,Arachchi Niranjan⁹,Knight Virginia¹,Dev Anouk¹

Affiliation:

1. Department of Gastroenterology, Monash Health, Victoria, Australia;

2. AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, New South Wales, Australia;

3. Department of Gastroenterology and Hepatology, Royal Melbourne Hospital, Victoria, Australia;

4. Department of Gastroenterology, St Vincent's Hospital, Victoria, Australia;

5. Department of Gastroenterology, Box Hill Hospital, Eastern Health, Victoria, Australia;

6. Department of Gastroenterology, Austin Health, Victoria, Australia;

7. Department of Surgery, Austin Health, Melbourne, Victoria, Australia;

8. Department of Gastroenterology, Alfred Hospital, Victoria, Australia;

9. Department of Gastroenterology, Western Hospital, Victoria, Australia

Publisher

Informa UK Limited